Data / Form D filings / RADIENT PHARMACEUTICALS Corp
RADIENT PHARMACEUTICALS Corp: Form D filings
RADIENT PHARMACEUTICALS Corp, a pharmaceuticals company in Tustin, CA, filed 5 Form D notices with the SEC between 2009 and 2011. The latest, on December 12, 2011, reports an offering of $18 million with nothing sold yet to 5 investors.
Find out what RADIENT PHARMACEUTICALS Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2492 WALNUT AVENUE, STE 100, Tustin, CA, 92780
- Phone
- (714) 505-4460
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 838879
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2011 | New notice | $18,000,112 | $0 | $18,000,112 | 5 | Nov 28, 2011 | sec.gov |
| Feb 14, 2011 | New notice | $8,437,500 | $8,437,500 | $0 | 5 | Jan 31, 2011 | sec.gov |
| Apr 30, 2010 | New notice | $11,027,000 | $11,027,000 | $0 | 36 | Mar 22, 2010 | sec.gov |
| Feb 2, 2010 | New notice | $3,666,988 | $0 | $3,666,988 | 0 | Yet to occur | sec.gov |
| May 7, 2009 | New notice | $2,500,000 | $1,327,250 | $1,172,750 | 37 | May 4, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Akio Ariura | Executive Officer | |
| Douglas Maclellan | Executive Officer | |
| Robert Beart | Director | |
| Michael Boswell | Director | |
| Robert Rooks | Director | |
| Leonard Reyno | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 12, 2011 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RADIENT PHARMACEUTICALS Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.